FundedIQ
Biotechnology

Precision Neuroscience: Funding, Investors & Team (Oct 2026)

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. We are building the only brain–computer interface that is designed to be minimally invasive, safely removable, and capable of processing large amounts of data. To learn more about how Precision is connecting human intelligence and artificial intelligence, visit www.precisionneuro.io.

precisionneuro.io LinkedIn New York, United States 11-50 employees Founded 2021
Medical Medical Device Neuroscience Product Research B2B
Total raised
$430M
Rounds
6
Latest
Series D
Sep 2026

Precision Neuroscience has raised $430M across 6 funding rounds on record, the most recent a Series D of $250M announced in Sep 2026.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Precision Neuroscience Company Profile and Key Stats

Total funding raised
$430M
across 6 rounds on record
Funding rounds on record
6
1 with no disclosed amount
Latest funding round
Series D
$250M in Sep 2026
Employees
11-50
reported band
Founded
2021
Headquarters
New York, United States
Investors on record
23
5 named below

Latest funding round on record: Sep 2026.

Precision Neuroscience Funding Rounds

Date
Round
Amount
Series D
$250M
Undisclosed round
Undisclosed
Series C
$93.0M
Series B
$41.0M
Undisclosed round
$34.3M
Undisclosed round
$12.0M

1 of 6 rounds was announced without a disclosed amount and is excluded from the total.

Precision Neuroscience raised $12.0M in an undisclosed round announced in May 2021.

1.6 years later, an undisclosed round of $34.3M was announced in Dec 2022.

1 month later, a Series B of $41.0M was announced in Jan 2023.

1.8 years later, a Series C of $93.0M was announced in Nov 2024.

1 years later, an undisclosed round was announced in Nov 2025 with no disclosed amount.

10 months later, a Series D of $250M was announced in Sep 2026.

Precision Neuroscience Investors

Ackman Oxman Institute Alumni Ventures ARK Investment Management Mubadala Capital Draper Associates

23 investors are recorded in total; the 5 named above are those the record identifies.

Precision Neuroscience Founders and Leadership Team

Name
Role
Contact
Demetrios Papageorgiou
Founder
Locked
Mark Hettick
Founder
Locked
Michael Mager
CEO
Locked
Ruthie Forney
Vice President of Product
Locked

Contact details for the Precision Neuroscience team: 4 of 4 have an email address on file, 2 have a LinkedIn profile.

Start 14-day free trial →

Precision Neuroscience Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
782
$99M

Precision Neuroscience's latest round of $250M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Precision Neuroscience in Biotechnology and New York

Companies Similar to Precision Neuroscience

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Precision Neuroscience Funding FAQs

What does Precision Neuroscience do?

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. We are building the only brain–computer interface that is designed to be minimally invasive, safely removable, and capable of processing large amounts of data. To learn more about how Precision is connecting human intelligence and artificial intelligence, visit www.precisionneuro.io.

How much funding has Precision Neuroscience raised?

Precision Neuroscience has raised $430M across 6 rounds on record. The most recent is a Series D of $250M announced in Sep 2026.

When did Precision Neuroscience last raise funding?

Precision Neuroscience's most recent funding round on record is a Series D of $250M, announced in Sep 2026.

Who has invested in Precision Neuroscience?

Investors on record for Precision Neuroscience include Ackman Oxman Institute, Alumni Ventures, ARK Investment Management, Mubadala Capital, Draper Associates. FundedIQ records 23 investors in total.

Who founded Precision Neuroscience?

FundedIQ lists Demetrios Papageorgiou (Founder), Mark Hettick (Founder) at Precision Neuroscience.

Who is the CEO of Precision Neuroscience?

Michael Mager is listed as CEO at Precision Neuroscience.

Where is Precision Neuroscience headquartered?

Precision Neuroscience is based in New York, United States.

How many employees does Precision Neuroscience have?

Precision Neuroscience is in the 11-50 employee band.

When was Precision Neuroscience founded?

Precision Neuroscience was founded in 2021.

How does Precision Neuroscience's funding compare to other Biotechnology startups?

Precision Neuroscience's latest round of $250M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Precision Neuroscience Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Precision Neuroscience is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.